Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Total Debt (2016 - 2025)

Historic Total Debt for Adma Biologics (ADMA) over the last 13 years, with Q3 2025 value amounting to $72.4 million.

  • Adma Biologics' Total Debt fell 2851.98% to $72.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.4 million, marking a year-over-year decrease of 2851.98%. This contributed to the annual value of $72.3 million for FY2024, which is 4460.92% down from last year.
  • Latest data reveals that Adma Biologics reported Total Debt of $72.4 million as of Q3 2025, which was down 2851.98% from $73.4 million recorded in Q2 2025.
  • Adma Biologics' 5-year Total Debt high stood at $144.3 million for Q1 2023, and its period low was $72.3 million during Q4 2024.
  • For the 5-year period, Adma Biologics' Total Debt averaged around $113.2 million, with its median value being $130.6 million (2023).
  • Its Total Debt has fluctuated over the past 5 years, first skyrocketed by 5056.25% in 2022, then plummeted by 4460.92% in 2024.
  • Quarter analysis of 5 years shows Adma Biologics' Total Debt stood at $94.9 million in 2021, then soared by 50.56% to $142.8 million in 2022, then decreased by 8.57% to $130.6 million in 2023, then tumbled by 44.61% to $72.3 million in 2024, then grew by 0.13% to $72.4 million in 2025.
  • Its Total Debt was $72.4 million in Q3 2025, compared to $73.4 million in Q2 2025 and $72.5 million in Q1 2025.